| MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study JM Mitchell, M Bogenschutz, A Lilienstein, C Harrison, S Kleiman, ... Focus 21 (3), 315-328, 2023 | 591 | 2023 |
| Electroencephalographic spectral and coherence analysis of ketamine in rats: correlation with behavioral effects and pharmacokinetics T Páleníček, M Fujáková, M Brunovský, M Balíková, J Horáček, I Gorman, ... Neuropsychobiology 63 (4), 202-218, 2011 | 103 | 2011 |
| Psychedelic harm reduction and integration: A transtheoretical model for clinical practice I Gorman, EM Nielson, A Molinar, K Cassidy, J Sabbagh Frontiers in psychology 12, 645246, 2021 | 93 | 2021 |
| Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2, 5-dimethoxyphenethylamine (2C-B) in rats T Páleníček, M Fujáková, M Brunovský, J Horáček, I Gorman, M Balíková, ... Psychopharmacology 225, 75-93, 2013 | 60 | 2013 |
| Posttraumatic growth after MDMA‐assisted psychotherapy for posttraumatic stress disorder I Gorman, AB Belser, L Jerome, C Hennigan, B Shechet, S Hamilton, ... Journal of traumatic stress 33 (2), 161-170, 2020 | 41 | 2020 |
| The effect of ((−)-2-oxa-4-aminobicyclo [3.1. 0] hexane-2, 6-dicarboxylic acid (LY379268), an mGlu2/3 receptor agonist, on EEG power spectra and coherence in ketamine model of … M Fujáková, T Páleníček, M Brunovský, I Gorman, F Tylš, A Kubešová, ... Pharmacology Biochemistry and Behavior 122, 212-221, 2014 | 19 | 2014 |
| Use of LSD by mental health professionals P Winkler, I Gorman, R Kočárová Neuropathology of drug addictions and substance misuse, 773-781, 2016 | 6 | 2016 |
| Investigation of the mechanisms mediating MDMA “Ecstasy”-induced increases in cerebro-cortical perfusion determined by btASL MRI J Rouine, ME Kelly, C Jennings-Murphy, P Duffy, I Gorman, S Gormley, ... Psychopharmacology 232, 1501-1513, 2015 | 4 | 2015 |
| Call for evidence-based psychedelic integration. J Greń, I Gorman, A Ruban, F Tylš, S Bhatt, M Aixalà Experimental and Clinical Psychopharmacology, 2023 | 3 | 2023 |
| The effect of ketamine on sensorimotor gating, EEG spectra and coherence-comparison of human and animal data T Palenicek, M Brunovsky, J Horacek, M Fujakova, I Gorman, F Tyls, ... Int J Neuropsychopharmacol 13, 231-232, 2010 | 2 | 2010 |
| Social norm feedback in online based smoking cessation: Do actual norms matter? I Gorman The New School, 2017 | | 2017 |
| Contents Vol. 63, 2011 MA García-Herráiz, MI Ramos-Fuentes, A Dietrich-Muszalska, B Kontek, ... Neuropsychobiology 63 (4), I-IV, 2011 | | 2011 |
| BEHAVIORAL PHARMACOLOGY OF THE PSYCHEDELIC 4-BROMO-2, 5-DIMETHOXYPHENYLETHYLAMINE (2C-B) T Palenicek, I Gorman, M Fujakova, L Rambousek, ... BEHAVIOURAL PHARMACOLOGY 21 (5-6), 592-592, 2010 | | 2010 |
| THE EFFECT OF REPEATED ADMINISTRATION OF MDMA ON THE NOVEL OBJECT RECOGNITION TEST AND PASSIVE AVOIDANCE TASK V Bubenikova-Valesova, M Mertlova, I Gorman BEHAVIOURAL PHARMACOLOGY 21 (5-6), 588-588, 2010 | | 2010 |
| A potential antipsychotic effect of group II metabotropic glutamate receptor agonist, LY379268, on behavioral changes and quantitative electroencephalography in rats in … M Fujakova, T Palenicek, M Brunovsky, V Bubenikova-Valesova, ... INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY 13, 91-92, 2010 | | 2010 |
| Pharmacological profile of a synthetic hallucinogen 4-bromo-2, 5-dimethoxyphenylethylamine (2C-B, Nexus) T PÁLENÍČEK, I Gorman, M Fujakova, V BUBENÍKOVÁ-VALEŠOVÁ, ... INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY 13, 55-55, 2010 | | 2010 |
| P. 6. d. 022 The role of serotonin and dopamine systems in the action of the psychedelic 4-bromo-2, 5-dimethoxyphenylethylamine (2C-B) T Palenicek, M Fujakova, I Gorman, L Rambousek, ... European Neuropsychopharmacology, S600-S601, 2010 | | 2010 |
| Effect of group II metabotropic glutamate receptor agonist on behaviour and electroencephalography in a model of psychosis M Fujakova, T Palenicek, I Gorman, M Brunovsky European Neuropsychopharmacology 20 (S3), 273-274, 2010 | | 2010 |
| THE EFFECT MGLU2/3 RECEPTOR AGONIST LY379268 ON BEHAVIOR IN KETAMINE-INDUCED MODEL OF PSYCHOSES T PÁLENÍČEK, V BUBENÍKOVÁ-VALEŠOVÁ, J HORÁČEK, M FUJÁKOVÁ, ... PSYCHIATRIE Учредители: Medica-Press International 13 (4), 191-194, 2009 | | 2009 |
| Behavioral, Neurochemical and Pharmaco-EEG Profiles of the Psychedelic Drug 4-bromo-2, 5-dimethoxyphenethylamine (2C-B) in Rats B Patophysiology, M Fujáková, PP Center, M Brunovský, J Horáček, ... | | |
Martin BrunovskyNational Institute of Mental HealthVerified email at nudz.cz
